With the automation of cleanrooms set to continue for the foreseeable future, considering best practice approaches for integrating mobile robotics in a pharma-compliant manner will be key for addressing the needs of the industry. This Insight article explores some of the potential obstacles to the adoption of mobile robotics and considers how they could be addressed.

The quality control labs of the future have been envisioned as fully-integrated environments, automated through the capture of data in real-time. By developing labs with digital output in mind, researchers at all scales can plan for the future and refine their approach to lab digitalisation.

Key opinion leaders discuss how to approach challenges and opportunities which arise when looking to optimise lab processes.

Robot healthcare assistants designed to operate in outer space may sound like science fiction, but the reality is incredibly feasible. In this Commentary article, Daniel Leidner explains how telerobotics-enabled hardware is currently being trialled in different laboratory environments as a means of providing remote healthcare.

In this Insight article, we explore SiLA: the consortium for Standardisation in Lab Automation, and look at some of the opportunities and challenges presented in the vision for a fully integrated laboratory environment.

Key opinion leaders from GSK and the University of Southampton discuss the steps needed to reach the lab of the future.

The pharma industry is embracing digitalisation of the lab. Recent advancements in paperless technology and AI offer a peek into what the smart labs of the future will look like.

By taking a more holistic approach to the design of mobile robots, cleanroom automation and aseptic production in the manufacture of pharmaceutical therapeutics could be made into a reality.

Could integrating robots such as the CellQualia System into stem cell development pipelines be key to advancing these therapies?

Key opinion leaders discuss the latest trends and challenges in laboratory automation and digitalization. Key insights include an explanation of Roche's 'Levers of Production' method, the challenges of legacy systems and the possibility of digitalization overload.

The pharmaceutical industry is working on improving the usability of automation platforms but challenges remain.